Roche has beaten analysts’ revenue forecasts in the third quarter, after mounting sales of its older drugs in China and the success of newer drugs mitigated the impact of patent expiries.
US biotech SQZ Biotechnologies has expanded a collaboration with Roche to develop cancer therapies based on antigen presenting cells, which may be able to target solid tumours and which are
Digital pathology startup Deep Lens has unveiled an artificial intelligence (AI) platform that will enable pathologists to diagnose cancer patients more swiftly and accurately.
Bristol-Myers Squibb has said its Opdivo immunotherapy has failed to improve on standard of care in patients with small cell lung cancer, who had relapsed following platinum-based chemother
